Healthy eating is continuing to gather pace in Japan and Roquette communicates regularly with nutrition experts on the latest developments in food, health and economy.
It was a great opportunity for Roquette to join the Annual Meeting of the Dietary Fiber Association and to give a conference on “The impacts of indigestible dextrin on gut comfort”. The conference introduced results of an in vivo mice study1 on the impact of NUTRIOSE® on intestinal well-being and immunity maintenance.
Irritable Bowel Syndrome (IBS) is the most common gastrointestinal disorder, affecting 20% of the population and characterized by abdominal pain and infraclinical intestinal inflammation. Fiber supplementation is a frequent treatment option in IBS, but the roles of fibers on intestinal pain and inflammation remain poorly known.
This study concludes that NUTRIOSE® significantly improved biological markers of abdominal pain and inflammation in mice. Such results advance our understanding of the effects of fiber on intestinal disorders and suggest that the prebiotic-like soluble fiber NUTRIOSE® may be a safe and promising treatment for IBS patients.
Roquette’s experts remain available to provide in-depth answers to any questions you may have.
Sources:
1LEFRANC-MILLOT C. WILS D, DEREMAUX L., ROUSSEAUX C, SANIEZ-DEGRAVE MH, DESREUMAUX P.
Impact of a new resistant dextrin on intestinal well-being and immunity maintenance.
FENS - IUNS Congress: 10th European Nutrition Conference 2007- Paris, France, 10-13 July
Our contact details are: